CryoLife Signs Definitive Agreement to Acquire Cardiogenesis
CryoLife, an implantable biological medical device and cardiovascular tissue processing company, agreed to acquire surgical product maker, Cardiogenesis Corp. for about $22 million.
tmr
Cardiogenesis Breaks Ground on Heart-Pumping New Research
Cardiogenesis, the clinical and market leader in transmyocardial revascularization (TMR), revealed this week that it has enrolled its first two patients for its feasibility study involving the cutting-edge PHOENIX System.
Cardiogenesis Lightens the Situation for Angina Sufferers
Cardiogenesis, a medical device company that develops tools for the treatment of ischemic cardiac disease, has helped numerous heart-disease patients with the use of laser therapy.